Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.
about
Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis.Current therapeutic landscape for advanced gastroesophageal cancers.Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer
P2860
Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Second- and third-line systemi ...... atic review of the literature.
@ast
Second- and third-line systemi ...... atic review of the literature.
@en
type
label
Second- and third-line systemi ...... atic review of the literature.
@ast
Second- and third-line systemi ...... atic review of the literature.
@en
prefLabel
Second- and third-line systemi ...... atic review of the literature.
@ast
Second- and third-line systemi ...... atic review of the literature.
@en
P2093
P2860
P31
P921
P1476
Second- and third-line systemi ...... matic review of the literature
@en
P2093
Emil Ter Veer
Hanneke W M van Laarhoven
Lok Lam Ngai
Martijn G H van Oijen
Nadia Haj Mohammad
Rosa M A Mali
P2860
P2888
P304
P356
10.1007/S10555-016-9632-2
P5008
P577
2016-09-01T00:00:00Z
P6179
1012087318